The Changing Landscape of Medicare Part D and Dermatologic Care

Dermatologists should anticipate increased utilization management for Part D-covered therapies, including more frequent prior authorization, step therapy requirements, and formulary changes.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/changing-landscape-medicare-part-d-and-dermatologic-care-2026a100050t
via IFTTT

New Survival Data With Osimertinib Reinforce Gains Seen Years Ago With Other EGFR TKIs

Dr Mark Kris examines new OS results for chemo plus osimertinib in EGFR-mutant NSCLC and how they align with survival gains seen previously with other EGFR TKIs.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/s/viewarticle/new-survival-data-osimertinib-reinforce-gains-seen-years-ago-2026a100042d
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started